1. Report Industry Investment Rating - Currently, the report has a phased and clear bullish view on the bond market [1]. 2. Core Viewpoints of the Report - The revenue growth rate of the entire A-share market and the return on 10-year Treasury bonds are relatively consistent, and the economy may have stabilized at a low level in the first half of 2025, but there is still downward pressure [1][4]. - The loan growth rate continues to decline, the proportion of loans on the asset side of banks tends to decrease, and the financial investment proportion of large banks has increased since early 2023 [1]. - The cost rate of interest-bearing liabilities of listed banks has declined quarter by quarter, and it is expected to further decline in the next few years [1]. - The decline in bank liability costs will support the bond yield to oscillate downward, and it is recommended to increase the allocation of government bonds [1]. 3. Summary by Relevant Catalogues 3.1 From the Semi-annual Report of the Entire A-share Market to See the Economic and Bank Operating Pressures - **From the Performance of the Entire A-share Market to See the Economy** - The revenue growth rate of the entire A-share market can reflect the nominal GDP growth rate to a certain extent, and it is more consistent with the return on 10-year Treasury bonds than the nominal GDP growth rate [5][6]. - In the first half of 2025, the revenue growth rate of the entire A-share market was 0.0%, and the net profit growth rate attributable to the parent was 2.4%. The growth rate of the entire A-share market excluding finance, petroleum, and petrochemicals was under pressure, reflecting the large pressure on real - economy growth [4][10]. - **From the Performance of the Bank Sector to See the Economy** - The performance of the banking industry is closely related to the economy. In the past two years, the performance growth of the banking industry has been significantly under pressure, and the net interest margin of commercial banks has continued to decline [13][16]. - As of the second quarter of 2025, the net interest margin of commercial banks was 1.42%, a record low, and the average net interest margin of various types of listed banks has also decreased significantly [16][18]. - **From the Liabilities of the Entire A-share Market to See the Financing Demand** - Since the first quarter of 2024, the long - term borrowing of the entire A - share market (excluding finance, petroleum, and petrochemicals) has stagnated, reflecting the weak financing demand of market - oriented enterprises [20]. - The social financing growth rate generally leads the nominal GDP growth rate by 1 - 2 quarters, and the social financing growth rate may decline in the next few months [23]. 3.2 What Changes Have Occurred in the Bank's Assets and Liabilities? - **The Loan Growth Rates of Large and Small and Medium - Sized Banks Have Both Declined** - As of the end of July 2025, the balance of RMB loans of financial institutions was 268.5 trillion yuan, with a year - on - year growth rate of 6.9%, the lowest level since the beginning of 2011 [25]. - The growth rate of personal housing loans is under pressure of negative growth, and the loan growth rates of large and small and medium - sized banks have both declined. The proportion of loans of listed banks has tended to decline since the second quarter of 2024 [25][29]. - **The Proportion of Deposits on the Liability Side of Large Banks Has Decreased, and the Proportion of Deposits of Small and Medium - Sized Banks Has Remained Stable** - Since early 2023, the proportion of deposits of the six major banks has decreased from 81.4% in the first quarter of 2023 to 76.0% in the second quarter of 2025, while the average proportion of deposits of listed joint - stock banks has increased [25]. - The large - scale banks' corporate deposit growth has slowed down, and the large - scale banks' dependence on non - bank inter - bank deposits has increased [39][45]. 3.3 Which Banks Had More Financial Investment Growth in the First Half of 2025? - Since early 2023, the proportion of financial investment of large banks has rebounded. As of the end of June 2025, the overall financial investment of A - share listed banks reached 97.4 trillion yuan, accounting for 30.3% of assets [51]. - In the first half of 2025, ICBC and CCB had more financial investment growth, while a small number of joint - stock banks' financial investment decreased. The financial investment increments of large banks, joint - stock banks, and city and rural commercial banks were all significant [55][59]. - As of the end of July 2025, the year - on - year growth rate of the bond investment of the four major banks reached 21.2%, the highest since 2017, and that of small and medium - sized banks was 18.3% [60]. 3.4 How Much Has the Cost of Interest - Bearing Liabilities of Banks Decreased? - In 2025, the decline of the current deposit ratio has slowed down. Since early 2018, the current deposit ratio has dropped significantly, and it is expected to further decline in the future, but the decline rate may slow down [61]. - Since the beginning of 2024, the deposit interest - payment rate has decreased significantly. The overall deposit interest - payment rate of A - share listed banks in the first half of 2025 was 1.65%, a year - on - year decrease of 32BP [65]. - The cost rate of interest - bearing liabilities has declined quarter by quarter. It is expected to further decline in the next few years, and may drop below 1.65% in the fourth quarter of 2025 [67]. 3.5 Investment Suggestions - It is expected that the liability cost of commercial banks will decline year by year in the next five years, which will support the bond yield to oscillate downward, and the return on 10 - year Treasury bonds will follow the decline of bank interest - bearing liabilities [69]. - In the low - interest - rate era, it is recommended to reduce the return expectation of bond investment, and commercial bank self - operation should increase the allocation of government bonds [72][73].

Investment Rating - The investment rating for the pharmaceutical industry is "Positive" (maintained) [4] Core Viewpoints - The pharmaceutical sector is experiencing a transformation, with traditional Big Pharma companies accelerating their innovation and research investments, leading to a potential revaluation of their market value [3][8] - The report emphasizes the importance of innovative drugs as a key growth driver, with a focus on companies that have shown significant improvements in their operational trends and clinical pipelines [5][35] Summary by Sections Industry Performance - From September 1 to September 5, the pharmaceutical index rose by 1.40%, outperforming the CSI 300 index by 2.21% [5] - Notable stock performances included Haichen Pharmaceutical (+29%), Changchun High-tech (+24%), and Baihua Pharmaceutical (+21%) [5] Traditional Pharma Revaluation - Since the implementation of drug procurement policies in 2018, traditional Big Pharma has faced revenue and profit pressures, prompting a shift towards innovation and increased R&D spending [8] - Key factors for the improvement in Big Pharma include rapid revenue/profit growth, increased R&D investment, and a decline in sales/administrative expenses [9][16] Innovation as a Growth Engine - The transition from generic to innovative drugs is becoming the core internal growth driver for Big Pharma, with significant increases in innovative revenue and its proportion of total income [22][27] - For instance, Heng Rui Medicine reported innovative drug sales of 95.61 billion RMB in the first half of 2025, accounting for 60.66% of total revenue [22] Clinical Pipeline and Global Competitiveness - The long-term R&D investments have resulted in a robust clinical pipeline for Big Pharma, with many products in advanced stages of development, enhancing their global competitiveness [29] - The report highlights the potential for business development (BD) opportunities abroad, which could serve as a second growth curve for these companies [29] Investment Recommendations - The report suggests focusing on innovative drugs, manufacturing, and companies with low valuations that are positioned to benefit from aging populations and increased healthcare consumption [35] - Specific companies to watch include Heng Rui Medicine, Xinlitai, and China National Pharmaceutical Group [35]

Investment Rating - The investment rating for the industry is "Positive" (maintained) [4] Core Viewpoints - The acceleration of renewable energy subsidies is expected to significantly improve cash flow and valuation levels for companies in the renewable energy sector, particularly for new energy operators and biomass/waste incineration power generation companies [5][6][16] - The recent issuance of renewable energy subsidies has exceeded expectations, with the total amount received from January to August 2025 far surpassing the entire year of 2024, primarily due to a large subsidy disbursed in August [11][12] - The recovery of accounts receivable is anticipated to enhance cash flow and improve balance sheets, which will positively impact stock valuations in the Hong Kong market [6][16] Summary by Sections Renewable Energy Sector - The total subsidies received by renewable energy companies from January to August 2025 have already reached significant levels, with many companies receiving around 70% of their total subsidies in August alone [5][11] - Companies such as Datang New Energy, China Power, and Longyuan Power are recommended based on their potential for improved cash flow from receivables [6][16] Biomass and Waste Incineration Power Generation - The report highlights that biomass power generation companies are also expected to benefit from the subsidy disbursement, with companies like China Everbright Environment and Shaoneng Co. being recommended for their potential higher dividend capabilities post-receivable recovery [6][16] Energy Storage Sector - The average price of square lithium iron phosphate energy storage cells has seen a slight increase, with domestic demand remaining strong and production capacity utilization rates high [7][18] - The domestic new energy storage project bidding scale reached 56.1GW/213.8GWh from January to July 2025, indicating a year-on-year growth of 181% [19] - The report suggests that companies like CATL, Yiwei Lithium Energy, and Guoxuan High-Tech are worth watching due to their expected performance elasticity amid rising energy storage cell prices [18][19]

Investment Rating - The investment rating for the industry is "Positive" (maintained) [4] Core Insights - The report highlights the strong brand power of the leading company in the folding bicycle sector, which holds a market share of 26.3% in retail volume and 36.5% in retail value as of 2024 [4] - The company has established a robust distribution network with 38 dealers across 30 provincial-level regions in China, covering 680 retail points, with domestic dealer revenue constituting 68% of total revenue in 2024 [4] - The product lineup includes five major series tailored for specific customer segments and usage scenarios, showcasing diverse performance features [4] - Recent government policies are expected to stimulate the growth of the sports industry in China, with a projected total scale exceeding 7 trillion yuan by 2030 [5] Summary by Sections Industry Performance - The new consumption sector has shown varied performance, with the textile and apparel index increasing by 1.37% and the retail index decreasing by 0.59% during the week of September 1 to September 5, 2025 [9] Key Industry Data - Retail sales in July for various categories showed growth, with jewelry sales increasing by 8.2% year-on-year [17] Investment Analysis - The report suggests focusing on high-quality domestic brands in emerging consumer goods, particularly in beauty, jewelry, and tea beverage sectors, which resonate well with younger consumers [22]

Investment Rating - The investment rating for the non-ferrous metals industry is "Positive" (maintained) [5] Core Views - The report highlights that the expectation of a rate cut by the Federal Reserve in September is likely to support copper prices, with recent price changes showing a slight increase in copper prices [4][6] - The report emphasizes the importance of monitoring the Federal Reserve's rate cut decision and the demand during the peak season of September and October [6] Summary by Sections 1. Industry Overview - The report notes that the U.S. manufacturing PMI for August was below expectations, indicating potential economic weakness [10] - The U.S. non-farm employment data for August was significantly lower than expected, which may influence market sentiment [10] 2. Market Performance - The non-ferrous metals sector outperformed the Shanghai Composite Index, with a weekly increase of 2.12% compared to a decline of 1.18% in the index [12] - Key stocks that performed well include Western Mining and Coldray Cobalt, while others like Shenghe Resources and Beikong Technology lagged [12] 3. Valuation Changes - The TTM PE for the non-ferrous metals sector is reported at 24.04, with a slight decrease of 0.31 [21] - The PB for the sector stands at 2.88, also showing a minor decrease [21] 4. Copper - Copper prices saw an increase of 0.73% in London and 0.92% in Shanghai, while New York copper prices fell by 0.91% [26] - The report indicates a decrease in London copper inventory by 0.60% and an increase in Shanghai copper inventory by 2.64% [26] 5. Aluminum - Aluminum prices decreased slightly, with London aluminum down by 0.11% and Shanghai aluminum down by 0.29% [38] - The report notes a rise in aluminum production costs and a slight increase in profit margins for aluminum producers [38] 6. Lithium - Lithium carbonate prices fell by 6.15% to 74,750 yuan per ton, while lithium hydroxide prices decreased by 1.76% [74] - The report suggests that the demand for lithium may rebound as inventory levels decrease during the peak season [74] 7. Cobalt - Cobalt prices increased, with MB cobalt rising by 1.27% to $15.95 per pound, and domestic cobalt prices also showing an upward trend [85] - The report highlights the impact of export bans from the Democratic Republic of Congo on cobalt supply and pricing [85]

Group 1 - In the first half of 2025, 635 public funds held a total market value of 22.4 billion yuan in companies listed on the Beijing Stock Exchange, representing a 76% increase compared to the previous period [2][9][11] - The proportion of public fund holdings in the Beijing Stock Exchange reached a historical high of 0.37%, up 0.15 percentage points from the previous period, indicating increasing attention from public funds towards this market [11][12] - The number of public funds holding Beijing Stock Exchange companies has doubled compared to the previous year, with significant contributions from both index funds and non-theme active equity funds [12][9] Group 2 - Active equity funds have shown a significant concentration in leading and scarce sectors, with Jinbo Biological leading with a 31% allocation, reflecting a shift towards mid-cap stocks with growth potential [17][20] - The top 15 companies in active equity fund holdings accounted for 75% of the total allocation, indicating a trend towards focusing on high-quality stocks with reasonable valuations and strong growth prospects [17][20] - The active equity fund allocation in the beauty care sector surged to 31%, overtaking the power equipment sector as the largest allocation, highlighting a structural shift in investment focus [22][20] Group 3 - The Beijing Stock Exchange 50 Index has rebounded with a weekly increase of 2.79%, suggesting a positive outlook for the market [2][20] - The average price-to-earnings (PE) ratio for the Beijing Stock Exchange A-shares rose to 56 times, with daily trading volume recovering to 36 billion yuan [2][36][37] - The number of new companies registered and submitted for IPOs on the Beijing Stock Exchange indicates a normalization of new stock issuance processes [2][4]

Investment Rating - The investment rating for the company is "Accumulate" (首次) [5] Core Views - The company demonstrates steady growth in operating performance and has a rich product line through both organic and external expansion [5] - The company has expanded its product matrix and strengthened its technological capabilities, particularly in the consumer electronics and automotive electronics sectors [6] - The company has increased its R&D investment, which has led to a temporary decline in net profit but is expected to yield long-term benefits [6] Financial Performance Summary - In H1 2025, the company achieved revenue of 1.47 billion yuan, a year-on-year increase of 17.60%, while the net profit attributable to the parent company was 123 million yuan, a year-on-year decrease of 40.21% [6] - For Q2 2025, the company reported revenue of 785 million yuan, a year-on-year increase of 21.08% and a quarter-on-quarter increase of 14.54%, with a net profit of 59 million yuan, down 43.44% year-on-year and 6.81% quarter-on-quarter [6] - The company’s revenue forecast for 2023 to 2027 is projected to grow from 1.78 billion yuan in 2023 to 5.15 billion yuan in 2027, with corresponding growth rates of 36.87%, 44.19%, 28.62%, 25.90%, and 23.89% [5][7] - The net profit attributable to the parent company is expected to increase from 261 million yuan in 2023 to 683 million yuan in 2027, with growth rates of 6.16%, 17.43%, 3.33%, 45.41%, and 48.18% [5][7] Product Development and Market Position - The company has launched several new products in the consumer electronics sector, including piezoelectric drive chips and high-integration mobile power SoC, filling domestic technology gaps [6] - In the automotive electronics sector, the company has introduced automotive-grade high-speed CAN/CAN FD transceivers and new automotive-grade buck-boost converters [6] - The acquisition of 100% equity in Zhuhai Shengsheng Micro has enhanced the company's MCU chip design and development capabilities, solidifying its position in the embedded systems market [6]

Investment Rating - The investment rating for the company is "Buy" (maintained) [6] Core Views - The core view indicates that the main business related to urban gas is steadily growing, while the connection and smart services are putting short-term pressure on performance [6] Financial Performance Summary - In H1 2025, the company achieved revenue of 15.432 billion yuan, a year-on-year increase of 11.99%, while the net profit attributable to the parent company was 638 million yuan, a decrease of 13.61% [9] - The revenue for Q2 2025 was 7.919 billion yuan, with a year-on-year growth of 14.47%, but the net profit attributable to the parent company decreased by 12.50% [9] - The urban gas segment reported a net profit of 2.77 billion yuan, down 6.94%, while the gas resource segment saw a profit increase of 42.9% [9] Revenue and Profit Forecast - The company forecasts revenue for 2023, 2024, 2025E, 2026E, and 2027E to be 30.929 billion, 28.348 billion, 31.337 billion, 32.023 billion, and 32.809 billion yuan respectively, with growth rates of 2.88%, -8.34%, 10.54%, 2.19%, and 2.46% [8] - The net profit attributable to the parent company is expected to be 1.44 billion, 1.457 billion, 1.538 billion, 1.764 billion, and 2.068 billion yuan for the same years, with growth rates of 17.80%, 1.19%, 5.53%, 14.73%, and 17.21% [8] Segment Performance - The urban gas segment's revenue in H1 2025 was 8.222 billion yuan, with a 2.58% year-on-year increase, while the gas engineering and other businesses saw a revenue decline of 11.90% [9] - The gas resource segment achieved a net profit of 233 million yuan, with a significant increase in wholesale gas volume by 305.65% [9] - The comprehensive energy segment's revenue was boosted by the successful operation of a gas power plant, with a 113.54% increase in electricity generation [9] Valuation Metrics - The current price-to-earnings (P/E) ratios for 2025, 2026, and 2027 are projected to be 12.89, 12.22, and 10.65 respectively [8] - The expected return on equity (ROE) for 2025, 2026, and 2027 is estimated at 9.26%, 9.92%, and 10.80% respectively [8]

Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Views - The company's performance aligns with expectations, demonstrating growth resilience. In H1 2025, the company achieved revenue of 5.76 billion yuan, a year-on-year decline of 1.05%, while net profit attributable to shareholders was 970 million yuan, a year-on-year increase of 9% [6] - The company announced an interim dividend of 0.25 yuan per share, totaling 204 million yuan, which accounts for 21.08% of the net profit attributable to shareholders for H1 2025 [6] - The integration of Yuefeng Environmental exceeded market expectations, contributing to profit growth despite a high base from the previous year. The company is actively expanding its heating services and optimizing financing costs, which is expected to sustain high growth in performance for the second half of the year [6][8] Summary by Sections Market Performance - Closing price as of April 4, 2025, was 26.26 yuan, with a yearly high/low of 28.18/18.47 yuan [3] Financial Data - Total market capitalization is 21,411.02 million yuan, with a debt-to-asset ratio of 72.46% and net asset value per share of 16.90 yuan [3] Earnings Forecast and Valuation - Projected revenues for 2025-2027 are 13.721 billion, 15.526 billion, and 15.632 billion yuan respectively, with corresponding net profits of 1.976 billion, 2.263 billion, and 2.358 billion yuan [7][8] - The current price-to-earnings ratio (P/E) is projected to be 11, 9, and 9 times for 2025-2027 [8]

Investment Rating - The investment rating for the company is "Buy" (maintained) [6] Core Views - The company's Q2 performance was negatively impacted by poor wind conditions in Fujian province, leading to a decline in earnings. The report anticipates future approvals for offshore wind projects in Fujian [6][7] - The company is expected to benefit from favorable policies for existing wind power projects, which will help secure return rates [7] - The group has committed to injecting 1.2GW of offshore wind and 1.2GW of pumped storage capacity, which are expected to enhance profitability [7] Financial Summary - For 2023, the company is projected to achieve revenue of 1,732 million RMB, with a year-on-year decline of 3.30%. The revenue is expected to grow to 1,880 million RMB in 2025, reflecting a growth rate of 7.96% [6][8] - The net profit attributable to shareholders is forecasted to be 678 million RMB in 2023, decreasing by 6.94% year-on-year, and is expected to rise to 740 million RMB in 2025, with a growth rate of 13.69% [6][8] - The earnings per share (EPS) is projected to be 0.36 RMB in 2023, increasing to 0.39 RMB in 2025 [6][8] Market Performance - As of September 4, 2025, the closing price of the company's stock is 5.25 RMB, with a yearly high of 6.60 RMB and a low of 4.19 RMB [4] - The total market capitalization is approximately 9,990.73 million RMB [4]